Insights into Continuous Flow Systems in Pharmaceutical Manufacturing

This document is a research article that discusses the evolution and significance of continuous flow technology in the pharmaceutical manufacturing sector, particularly in Ireland. It outlines the transition from traditional batch manufacturing to continuous flow processes, emphasizing the advantages such as increased safety, efficiency, and flexibility. The article highlights the role of the Irish pharmaceutical landscape, which includes multinational companies and Contract Development and Manufacturing Organizations (CDMOs), in adopting these technologies. It also details the challenges faced in regulatory approval processes, noting the importance of compliance with frameworks like ICH Q8, Q9, Q10, and Q13. The document presents insights into the operational control strategies necessary for successful implementation, including process control, data management, and the establishment of robust design space limits. Furthermore, it emphasizes the collaborative efforts between academia and industry in advancing flow chemistry and training skilled professionals, which are crucial for the growth of this innovative manufacturing approach.